Virtual
Day Two: Biopharma Partnering - ET (Eastern Time, GMT-05:00)
Successful biopharma partnerships require more than capital—they demand strategic alignment across scientific innovation, commercial execution, and financial returns. This panel brings together industry leaders to explore how investors, operators, and innovators can bridge the gap between breakthrough science and market success. Panelists will discuss frameworks for structuring partnerships that balance risk and reward, strategies for aligning incentives across R&D, commercial, and financial stakeholders, and real-world examples of collaborations that delivered both therapeutic impact and sustainable value. Whether you're a founder seeking the right partner, an investor evaluating opportunities, or an executive navigating complex alliances, this session will provide actionable insights on building partnerships designed for mutual, long-term success.
Strategies for aligning scientific innovation with commercial and financial objectives
Building partnerships that balance risk, reward, and long-term value creation
Collaborative approaches to ensure mutual success across all stakeholders
- Hong Chen - Director, Search & Evaluation USA, Novo Nordisk
- Fei Shen - Head of BD&L USA, Boehringer Ingelheim Venture Fund